Effects of a Single Dose of Bright Light Treatment on Measures of Affective Information Processing

NCT03688048 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-10-03

No results posted yet for this study

Summary

This study aims to investigate the effects of a single session of bright light treatment (BLT) on emotional information processing in healthy volunteers. We hypothesised that BLT can acutely push the processing of emotional information towards a prioritisation of positive (relative to negative) input. To test this hypothesis, healthy volunteers were randomly allocated to receive either bright light treatment or sham-placebo treatment and study participants as well as investigators were blind as to which treatment was used. After treatment, all participants underwent testing with the Oxford Emotional Test Battery, an established set of psychological tasks that allow to assess how emotional information is processed.

Conditions

  • Bright Light Treatment
  • Emotion
  • Facial Expression Recognition

Interventions

DEVICE

Bright light treatment lamp

Exposure to bright white light (1 hour, 10 000 lux)

DEVICE

Sham negative ion generator

Placebo treatment with deactivated negative ion generator (1 hour, audible hum, no ions emitted)

Sponsors & Collaborators

  • Medical Research Council

    collaborator OTHER_GOV
  • P1vital Products Limited

    collaborator INDUSTRY
  • University of Oxford

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-20
Primary Completion
2018-03-16
Completion
2018-03-16

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03688048 on ClinicalTrials.gov